US Patent Issued to SHANDONG NEW TIME PHARMACEUTICAL on Nov. 11 for "Method of treatment using a bispecific antibody binding bcma and CD3" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,886, issued on Nov. 11, was assigned to SHANDONG NEW TIME PHARMACEUTICAL Co. LTD. (Linyi, China).

"Method of treatment using a bispecific antibody binding bcma and CD3" was invented by Qiang Li (Shanghai), Shixiang Jia (Shanghai), Lili Zhao (Linyi, China), Guimin Zhang (Linyi, China), Zhong Liu (Linyi, China), Xinlu Ma (Shanghai), Yuan Yan (Shanghai), Zhenyu Li (Linyi, China), Xingxia Hu (Linyi, China), Yuhua Zhang (Shanghai) and Bin Li (Linyi, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provided herein relates to methods and uses of a bispecific antibody, which specifically binds the surface antigen CD3 of immune cells and th...